Combination Chemotherapy for Advanced Urothelial Cancer With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-Vac)

Japanese Journal of Urology - Japan
doi 10.5980/jpnjurol1928.79.9_1510
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Japanese Urological Association

Related search

Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-Vac) in Advanced Urothelial Cancer

Japanese Journal of Urology
Urology
1991English

Sequential Methotrexate and 5-Fluorouracil, Doxorubicin, and Cisplatin for Advanced Urothelial Cancer

Japanese Journal of Urology
Urology
1992English

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced and or Metastatic Bilharzial Urothelial Carcinoma of the Bladder in Egypt.

Research in Oncology
2011English

Co-Administration of Dexamethasone Increases Severity and Accelerates Onset Day of Neutropenia in Bladder Cancer Patients on Methotrexate, Vinblastine, Adriamycin and Cisplatin Chemotherapy: A Retrospective Cohort Study

Journal of Pharmaceutical Health Care and Sciences
2017English

Choosing Chemotherapy in Patients With Advanced Urothelial Cell Cancer Who Are Unfit to Receive Cisplatin-Based Chemotherapy

Therapeutic Advances in Medical Oncology
Oncology
2010English

Role of Combination Chemotherapy With 5-Fluorouracil, Cisplatin and Paclitaxel for Advanced Gall Bladder Cancer

Journal of Cancer Therapy
2014English

Comparison of the Efficacy Between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2014English

Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma

Modern Chemotherapy
2013English

Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy